• HOME
  • COMPANY
  • KEY BUSINESS AREAS
  • R&D
 
 
     

 

Hyaluronic Acid

Platform

Hyaluronic acid is currently the standard in the context of implantable medical devices, which are used in specialised fields of medicine. Bioitech is developing a procedure for the use of Crosslinked Hyaluronic acid in the context of Ophthalmology and Aesthetics.
Research for the future focuses on physiological preparations that slow the degradation of Hyaluronic acid from hyaluronidase, by the addition of retardant polymers.
Finally, some studies are focused on finding those chemical changes that can amplify the rheological characteristics that have decreed the success of hyaluronic acid.

 

Key Business Areas


Carboxymethyl Cellulose Platform

EreLLe™

Hyaluronic Acid Platform

Syringe Components

Crossyal™

 

   

© 2012, BIOITECH S.r.l. All right reserved | C.F. e P.I. 10671701000 | Via Chiana, 87 00198 - Roma (Italy)